Healthcare Triangle Reports Third Quarter 2023 Results
13 Novembre 2023 - 2:15PM
Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the "Company"),
a leader in digital transformation solutions including managed
services, cloud enablement, cybersecurity, data analytics, and AI
data processing for the healthcare and life sciences industries,
today announced results for the third quarter of 2023 ended
September 30, 2023.
Thyagarajan Ramachandran, CFO of Healthcare
Triangle, said, “A return to predictable revenue growth is top
priority for the current quarter and throughout 2024. During the
third quarter we launched an exciting new initiative working with
U.S. health systems on an HCTI-branded ransomware protection
framework and methodology. The response so far has been
encouraging, and our goal is to become a top provider of
robust cybersecurity services to meet the widespread
accelerating demand for cyber preparedness in healthcare.
Another key area of focus is on driving adoption of our
high-performance readabl.ai solutions for cloud-scale,
AI-driven healthcare document workflow. HCTI is in discussions with
multiple life sciences companies about piloting generative AI use
cases in areas such as drug discovery and documentation AI. We are
also looking to expand business with our current pharma customers
in 2024 with new managed services opportunities in cloud DevOps and
data modernization projects. We are confident that these key
revenue drivers will support improved Company performance in the
coming quarters.”
Third Quarter 2023 Financial Results
- Total revenue
was $7.8 million, compared to $11.9 million in the third quarter of
2022. Revenue in the year-ago quarter included multiple one-time
EHR (electronic health record) implementations and short-term
consulting contracts.
- Loss from
operations was $1.5 million, compared to $2.2 million for the third
quarter of 2022.
- Basic and
diluted net loss per share was $0.46 based on 4.2 million
weighted-average shares outstanding, compared to basic and diluted
net loss per share of $0.64 based on 35.6 million weighted-average
shares outstanding for the third quarter of 2022.
Third Quarter 2023 and Recent Business
Highlights
- Closed $1.6
million of new business with existing customers.
- Spurred brand
awareness for the Company’s new ransomware protection and
prevention initiative through marketing activities.
- Hosted an
educational roundtable with hospital CXOs in collaboration with
Amazon Web Services about the role of generative AI and data
modernization technologies in improving patient outcomes, improving
clinical decision, streamlining healthcare operations and reducing
costs.
- Secured a
multi-year contract to customize and enhance electronic health
record (EHR) software for client-specific workflow and provide
managed support.
- Launched a
project for comprehensive development, testing, and go-live support
for Epic cloud-based EHR, including post-go-live stabilization
phases.
- Secured a design
and integration project for a SAP-SQL global data migration
solution for a pharmaceutical customer including 12 months of
continuous hypercare support.
- Secured a
contract extension from a top 5 customer for a public cloud-based
clinical HPC (high performance computing) project initiative.
About Healthcare Triangle
Healthcare Triangle, Inc. based in Pleasanton,
California, reinforces healthcare progress through breakthrough
technology and extensive industry knowledge and expertise. We
support healthcare including hospitals and health systems, payers,
and pharma/life sciences organizations in their effort to improve
health outcomes through better utilization of the data and
information technologies that they rely on. Healthcare Triangle
achieves HITRUST Certification for Cloud and Data Platform (CaDP),
marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2)
Certified status demonstrates to our clients the highest standards
for data protection and information security. Healthcare Triangle
enables the adoption of new technologies, data enlightenment,
business agility, and response to immediate business needs and
competitive threats. The highly regulated healthcare and life
sciences industries rely on Healthcare Triangle for expertise in
digital transformation encompassing the cloud, security and
compliance, identity management, data lifecycle management,
healthcare interoperability, and clinical and business performance
optimization. For more information,
visit www.healthcaretriangle.com.
Forward-Looking Statements and Safe Harbor
Notice
All statements other than statements of
historical facts included in this press release are
"forward-looking statements" (as defined in the Private Securities
Litigation Reform Act of 1995). Such forward-looking statements
include our expectations and those statements that use
forward-looking words such as "projected," "expect," "possibility"
and "anticipate." The achievement or success of the matters covered
by such forward-looking statements involve significant risks,
uncertainties and assumptions. Actual results could differ
materially from current projections or implied results. Investors
should read the risk factors set forth in the Company's Prospectus
filed with the SEC on October 7, 2021, previous filings, subsequent
filings and future periodic reports filed with the SEC. All the
Company's forward-looking statements are expressly qualified by all
such risk factors and other cautionary statements.
The Company cautions that statements and
assumptions made in this news release constitute forward-looking
statements and make no guarantee of future performance.
Forward-looking statements are based on estimates and opinions of
management at the time statements are made. The information set
forth herein speaks only as of the date hereof. The Company and its
management undertake no obligation to revise these statements
following the date of this news release.
Investor Contact
1-800-617-9550 ir@healthcaretriangle.com
Healthcare Triangle (NASDAQ:HCTI)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Healthcare Triangle (NASDAQ:HCTI)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025